Lv2
132 积分 2021-09-24 加入
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS
3个月前
已完结
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
3个月前
已完结
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
4个月前
已完结
P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent
4个月前
已完结
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial
4个月前
已完结
Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk
4个月前
已完结
Exploring the Role of SPARC in Atherosclerosis: Mechanisms and Potential Implications
6个月前
已完结
Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure
6个月前
已完结
Lipotoxicity as a therapeutic target in the type 2 diabetic heart
7个月前
已完结
Lipotoxicity in type 2 diabetic cardiomyopathy
7个月前
已完结
皖公网安备34019202002308
